D
Aurinia Pharmaceuticals Inc. AUPH
$8.18 $0.080.99% NASDAQ
Recommendation
Prev Close
$8.18
Volume
808,972
Avg Vol (90D)
1,368,288
Market Cap
$1.12B
Dividend & Yield
--
52-Week Range
$4.86 - $10.67
P/E (TTM)
201.98
EPS (TTM)
$0.0405
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth
4/26/2025 - Seeking Alpha - Long Ideas
Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth
4/26/2025 - SeekingAlpha
5,500 Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Purchased by Natixis
4/26/2025 - Ticker Report
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics
4/24/2025 - Zacks Investment Research
Aurinia Pharmaceuticals (AUPH, $8.09) price moved above its 50-day Moving Average on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms
4/23/2025 - Zacks Investment Research
Aurinia Pharmaceuticals (AUPH, $7.89) entered Uptrend as Momentum indicator ascends above 0 level on Apr 22, 2025
4/23/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $7.89) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 22, 2025
4/23/2025 - Tickeron - Stocks
XTX Topco Ltd Takes $384,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
4/23/2025 - Ticker Report
Vanguard Group Inc. Purchases 112,113 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
4/20/2025 - MarketBeat
Aurinia Pharmaceuticals (AUPH, $7.75) Stochastic Oscillator left the overbought zone on April 17, 2025
4/18/2025 - Tickeron - Technical Analysis
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Bought by Franklin Resources Inc.
4/17/2025 - MarketBeat
ExodusPoint Capital Management LP Buys New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
4/15/2025 - MarketBeat
Aurinia Pharmaceuticals (AUPH, $7.41) Stochastic Oscillator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Stocks
American Century Companies Inc. Has $1.54 Million Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
4/12/2025 - MarketBeat
Aurinia Pharmaceuticals (AUPH, $7.61) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $7.61) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $7.2) RSI Indicator left the oversold zone on April 08, 2025
4/9/2025 - Tickeron - Technical Analysis
How The Pieces Add Up: FHLC Targets $82
4/9/2025 - ETF Channel
Trexquant Investment LP Has $3.97 Million Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
4/7/2025 - MarketBeat
Aurinia Pharmaceuticals (AUPH, $7.81) price may climb as it broke lower Bollinger Band on Apr 04, 2025
4/5/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $8.05) price exceeded its 50-day Moving Average on April 03, 2025
4/4/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $8.19) price moved above its 50-day Moving Average on April 02, 2025
4/3/2025 - Tickeron - Stocks
Aurinia Pharmaceuticals (AUPH, $8.05) Stochastic Oscillator left the oversold zone on April 01, 2025
4/2/2025 - Tickeron - Stocks
Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues
4/1/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$235.13M
EBITDA (TTM)
$31.96M
EBIT (TTM)
$12.52M
Net Income (TTM)
$5.75M
Balance Sheet
Total Assets (Q)
$550.65M
Total Debt (Q)
$79.37M
Total Liabilities (Q)
$173.17M
Book Value Per Share (Q)
$2.68
Cash Flow
Cash from Operations (TTM)
$44.39M
Cash from Investing (TTM)
$39.26M
Cash from Financing (TTM)
-$49.09M
Net Change in Cash (TTM)
$34.56M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.35
7-Day Total Return
6.65%
30-Day Total Return
0.25%
60-Day Total Return
2.25%
90-Day Total Return
-12.70%
Year to Date Total Return
-6.73%
1-Year Total Return
66.60%
2-Year Total Return
-26.77%
3-Year Total Return
-25.16%
5-Year Total Return
-49.79%
52-week Low
Apr 26, 2024 - $4.86
52-week High
Dec 10, 2024 - $10.67
Valuation
Market Cap
$1.12B - Small Cap
Enterprise Value
$844.36M
Price/Sales (TTM)
5.14
Price/Book (Q)
3.05
Dividends and Shares
Shares Outstanding
147.68M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.auriniapharma.com
Phone Number
250 744 2487
Address
#140, 14315 – 118 Avenue
Edmonton, AB T5L 4S6
Country
Canada
Year Founded
1993
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed